Adient (NYSE:ADNT) Stock Price Target Lowered at JPMorgan Chase & Co.

Adient (NYSE:ADNT – Free Report) had its price target trimmed by JPMorgan Chase & Co. from $25.00 to $23.00 in a report released on Thursday morning,Benzinga reports. The firm currently has an overweight rating on the stock.

Other research analysts have also recently issued reports about the company. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and set a $28.00 price objective on shares of Adient in a report on Thursday, August 6th. Weiss Ratings downgraded shares of Adient from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Friday, August 21st. Zacks Research raised shares of Adient from a “strong sell” rating to a “hold” rating in a report on Wednesday, September 16th. UBS Group dropped their target price on shares of Adient from $29.00 to $23.00 and set a “buy” rating for the company in a research report on Wednesday, October 7th. Finally, Stifel Nicolaus cut their price target on shares of Adient from $26.00 to $21.00 and set a “buy” rating for the company in a report on Monday, October 19th. Seven analysts have rated the stock with a Buy rating, three have given a Hold rating and two have given a Sell rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $24.70.

Read Our Latest Analysis on ADNT

Adient Trading Down 0.4%

Shares of ADNT opened at $17.13 on Thursday. The company has a current ratio of 1.09, a quick ratio of 0.91 and a debt-to-equity ratio of 1.21. The stock has a market cap of $1.32 billion, a PE ratio of 9.19, a PEG ratio of 0.24 and a beta of 1.64. Adient has a 1 year low of $15.80 and a 1 year high of $27.32. The stock has a 50 day simple moving average of $17.82 and a 200-day simple moving average of $20.47.

Adient (NYSE:ADNT – Get Free Report) last announced its quarterly earnings results on Wednesday, November 4th. The company reported $0.52 EPS for the quarter, missing the consensus estimate of $0.64 by ($0.12). The company had revenue of $3.73 billion during the quarter, compared to analyst estimates of $3.62 billion. Adient had a negative net margin of 0.11% and a positive return on equity of 7.35%. Adient’s quarterly revenue was up 1.1% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.52 EPS. On average, sell-side analysts predict that Adient will post 3.11 EPS for the current fiscal year.

Insider Buying and Selling at Adient

In other news, Director Peter Carlin sold 7,843 shares of the firm’s stock in a transaction on Wednesday, September 2nd. The stock was sold at an average price of $19.25, for a total value of $150,977.75. Following the completion of the sale, the director directly owned 38,835 shares in the company, valued at approximately $747,573.75. This trade represents a 16.80% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Company insiders own 0.94% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Dimensional Fund Advisors LP increased its stake in shares of Adient by 5.1% in the 1st quarter. Dimensional Fund Advisors LP now owns 4,384,904 shares of the company’s stock valued at $88,614,000 after buying an additional 211,843 shares during the period. Arrowstreet Capital Limited Partnership raised its position in shares of Adient by 17.2% during the first quarter. Arrowstreet Capital Limited Partnership now owns 2,293,353 shares of the company’s stock worth $46,349,000 after acquiring an additional 336,306 shares during the last quarter. Bank of America Corp DE lifted its stake in shares of Adient by 61.7% during the first quarter. Bank of America Corp DE now owns 792,543 shares of the company’s stock valued at $16,017,000 after acquiring an additional 302,538 shares during the period. Empowered Funds LLC lifted its stake in shares of Adient by 23.5% during the first quarter. Empowered Funds LLC now owns 554,572 shares of the company’s stock valued at $11,208,000 after acquiring an additional 105,435 shares during the period. Finally, Healthcare of Ontario Pension Plan Trust Fund lifted its stake in shares of Adient by 179.3% during the first quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 527,356 shares of the company’s stock valued at $10,658,000 after acquiring an additional 338,517 shares during the period. Institutional investors and hedge funds own 92.44% of the company’s stock.

Adient News Summary

Here are the key news stories impacting Adient this week:

Adient Company Profile

(Get Free Report)

Adient plc (NYSE: ADNT) is a global automotive supplier specializing in the design, development and manufacture of vehicle seating systems. The company supplies complete seating assemblies as well as components such as seat structures, mechanisms, foam, fabrics, leather and other trim materials.

Adient works with automakers and other automotive customers to provide seating solutions for passenger cars, trucks, sport utility vehicles and commercial vehicles. Its offerings are designed to support vehicle comfort, safety, styling, weight reduction and manufacturing efficiency, with products developed for both traditional and electrified vehicles.

The company was formed in 2016 through the separation of Johnson Controls’ automotive seating business.

Further Reading

Analyst Recommendations for Adient (NYSE:ADNT)

Receive News & Ratings for Adient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adient and related companies with MarketBeat.com's FREE daily email newsletter.